Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-139196

Published: 2020

Journal Articles

Development of a Severity Score System for Thalassemia Syndromes

Blood (2019) 134 (Supplement_1): 2225.

https://doi.org/10.1182/blood-2019-124675

Published: 2019

Journal Articles

Male Gender Increases the Risk of Liver Fibrosis in Patients with Thalassemia Major Independent of Iron Overload

Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Said Al Busaifi, Al Ghaliya Al Omairi, MD, Moez Hassan, MD, Humoud Al Dhuhli, Umaima Al Ajmi, Sarah Al Rahbi, Shahina Daar, MD

Blood (2016) 128 (22): 3630.

https://doi.org/10.1182/blood.V128.22.3630.3630

Published: 2016

Journal Articles

Long-Term Iron Chelation Therapy with Deferiprone in Patients with Thalassemia Major and Low Iron Load

Shahina Daar, MD, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Khalil Al Farsi, Bader Abdulla Al-Rawahi, MD, Arwa Z. Al-Riyami, BSc,MD FRCPC

Blood (2016) 128 (22): 3626.

https://doi.org/10.1182/blood.V128.22.3626.3626

Published: 2016

Journal Articles

Genotype in Patients with Thalassemia Major Has No Impact on Risk of Liver Fibrosis

Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Shahina Daar, MD, Shoaib Al-Zedjali, Al Ghaliya Al Omairi, MD, Moez Hassan, MD, Sarah Al Rahbi, Abubakr Ibnouf, Said Al Busaifi

Blood (2016) 128 (22): 4835.

https://doi.org/10.1182/blood.V128.22.4835.4835

Published: 2016

Journal Articles

Dose Optimization of Deferasirox in Chelation Naïve Children with Thalassemia Major

Surekha Tony, MD, Murtadha K. Al-Khabori, MD, FRCPC, Ashraf Abdullah Saad, MBBS, Shahina Daar, MD, PhD, Mathew Zachariah, MD, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 5294.

https://doi.org/10.1182/blood.V118.21.5294.5294

Published: 2011

Journal Articles

Gonadal Function In Patients with Beta-Thalassemia Major Following Bone Marrow Transplantation,

Khalil Al Farsi, BSc MD ABIM FRCPC, Murtadha K. Al-Khabori, MD, FRCPC, Fehmida Zia, MBBS, Moez Abdul-Rahim, MBBS, Yusra Al-Habsi, BSc, Eman Al-Manthari, BSc, J. David Dennison, MD, Shahina Daar, MD, PhD

Blood (2011) 118 (21): 4105.

https://doi.org/10.1182/blood.V118.21.4105.4105

Published: 2011

Journal Articles

T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality

Surekha Tony, MD, Shahina Daar, MD, PhD, Shoaib Al Zadjali, MSc, Murtadha K. Al-Khabori, MD, FRCPC, Mohammed El Shinawy, MD, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 5304.

https://doi.org/10.1182/blood.V118.21.5304.5304

Published: 2011

Journal Articles

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration

Timothy G St Pierre, PhD, Amal El-Beshlawy, MD, Mohsen Saleh Elalfy, MD, Abdullah Al Jefri, MD, Kusai Al Zir, MD, Shahina Daar, MD, Dany Habr, MD, Ulrike Kriemler-Krahn, Ali Taher, MD

Blood (2010) 116 (21): 2053.

https://doi.org/10.1182/blood.V116.21.2053.2053

Published: 2010

Journal Articles

Risk Factors for Pulmonary Hypertension In Patients with Thalassemia Intermedia

Mehran Karimi, MD, Khaled M Musallam, MD, Maria Domenica Cappellini, MD, Amal El-Beshlawy, MD, Khawla Belhoul, MD, Shahina Daar, MD, Mohamed-SalahEldin Saned, MD, Sally Temraz, MD, Ali T Taher, MD

Blood (2010) 116 (21): 2069.

https://doi.org/10.1182/blood.V116.21.2069.2069

Published: 2010

Journal Articles

EARLY Detection of Cardiac and Hepatic Iron Overload by T2* Magnetic Resonance in Very Young Patients with Thalassemia Major in Oman

Surekha Tony, MD, Shahina Daar, MD, Mathew Zachariah, MD, Azza Hinai, MD, Idris Al-Jumah, MD, Salaam Alkindi, MBBCh, MSc, FRCP, Yasser Wali, MD, FRCPCH, (UK)

Blood (2010) 116 (21): 4262.

https://doi.org/10.1182/blood.V116.21.4262.4262

Published: 2010

Journal Articles

Newborn Haemoglobinopathy Carrier Screening: Towards Comprehensive and Improved Patient Care of Sickle Cell Disease in Oman, a Cost Effective Analysis.

Salam Alkindi, MD, Anil Pathare, MD, Ali Al Madhani, MD, Shoaib Al Zadjali, M.Sc, S. Muralitharan, Ph.D, Hamood Al Haddabi, M.Sc, Qamariya Al Abri, M.Sc, David Gravell, M.Sc, Shahina Daar, MD, J. David Dennison, MD, R. Krishnamoorthy, Ph.D

Blood (2007) 110 (11): 5155.

https://doi.org/10.1182/blood.V110.11.5155.5155

Published: 2007

Journal Articles

Cardioprotection by Deferiprone[L1] Inspite of Rising Serum Ferritin in Beta Thalassemia Major Patients.

Anil Pathare, MD, Shahina Daar, MD, Salam Alkindi, MD, J.David Dennison, MD

Blood (2005) 106 (11): 3816.

https://doi.org/10.1182/blood.V106.11.3816.3816

Published: 2005

Journal Articles

Suboptimal Busulphan Exposure Is Associated with Mixed Hematopoietic Chimerism, a Risk Factor for Rejection in Bone Marrow Transplantation for Homozygous beta Thalassemia.

J. David Dennison, MD, Shoaib Al Zadjali, Melanie Tauro, Salam Al Kindi, MD, S. Muralitharan, Krishnaratnam Kanan, MD, Shahina Daar, MD, Anil Pathare, MD, Marie-Helene Quernin, Evelyne Jacqz-Aigrain, MD, R. Krishnamoorthy, MD, Shyam Sundar Ganguly, MD

Blood (2004) 104 (11): 1149.

https://doi.org/10.1182/blood.V104.11.1149.1149

Published: 2004

Journal Articles

Efficient Iron Chelation Resulting in Improved Myocardial Performance with Combined Desferrioxamine and Deferiprone in Beta Thalassemia Major Patients.

Anil V. Pathare, MD, Shahina Daar, MD, Salam Al Kindi, MD, J. David Dennison, MD

Blood (2004) 104 (11): 3766.

https://doi.org/10.1182/blood.V104.11.3766.3766

Published: 2004

NARROW

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

Development of a Severity Score System for Thalassemia Syndromes

Male Gender Increases the Risk of Liver Fibrosis in Patients with Thalassemia Major Independent of Iron Overload

Long-Term Iron Chelation Therapy with Deferiprone in Patients with Thalassemia Major and Low Iron Load

Genotype in Patients with Thalassemia Major Has No Impact on Risk of Liver Fibrosis

Dose Optimization of Deferasirox in Chelation Naïve Children with Thalassemia Major

Gonadal Function In Patients with Beta-Thalassemia Major Following Bone Marrow Transplantation,

T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration

Risk Factors for Pulmonary Hypertension In Patients with Thalassemia Intermedia

EARLY Detection of Cardiac and Hepatic Iron Overload by T2* Magnetic Resonance in Very Young Patients with Thalassemia Major in Oman

Newborn Haemoglobinopathy Carrier Screening: Towards Comprehensive and Improved Patient Care of Sickle Cell Disease in Oman, a Cost Effective Analysis.

Cardioprotection by Deferiprone[L1] Inspite of Rising Serum Ferritin in Beta Thalassemia Major Patients.

Suboptimal Busulphan Exposure Is Associated with Mixed Hematopoietic Chimerism, a Risk Factor for Rejection in Bone Marrow Transplantation for Homozygous beta Thalassemia.

Efficient Iron Chelation Resulting in Improved Myocardial Performance with Combined Desferrioxamine and Deferiprone in Beta Thalassemia Major Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only